Cargando…
Serum IL-10 as a marker of severe dengue infection
BACKGROUND: Several studies have shown that serum IL-10, IFNγ and MIF are elevated in patients in severe dengue (SD) and could be used as potential biomarkers. We proceeded to determine if these cytokines could be used as biomarkers in a large cohort of adult dengue patients with varying severity of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733887/ https://www.ncbi.nlm.nih.gov/pubmed/23883139 http://dx.doi.org/10.1186/1471-2334-13-341 |
_version_ | 1782279425420689408 |
---|---|
author | Malavige, Gathsaurie Neelika Gomes, Laksiri Alles, Lukmall Chang, Thashi Salimi, Maryam Fernando, Sachie Nanayakkara, Kushan DL Jayaratne, SD Ogg, Graham S |
author_facet | Malavige, Gathsaurie Neelika Gomes, Laksiri Alles, Lukmall Chang, Thashi Salimi, Maryam Fernando, Sachie Nanayakkara, Kushan DL Jayaratne, SD Ogg, Graham S |
author_sort | Malavige, Gathsaurie Neelika |
collection | PubMed |
description | BACKGROUND: Several studies have shown that serum IL-10, IFNγ and MIF are elevated in patients in severe dengue (SD) and could be used as potential biomarkers. We proceeded to determine if these cytokines could be used as biomarkers in a large cohort of adult dengue patients with varying severity of dengue infection. METHODS: Serum IL-10 levels were determined in 259 of whom 40 had severe dengue infection. Serum IFNγ and IFNα levels were done in 78 and MIF levels were done in 65 patients with acute dengue infection. Clinical features and laboratory investigations were undertaken during the febrile and critical phase. RESULTS: We found that serum IL-10 levels were significantly higher (p = 0.001) in patients with SD, when compared to those with non SD. Serum IL-10 levels significantly and inversely correlated with white cell counts (R = −0.23, p = 0.0002) and lymphocyte counts (R = −0.29, p < 0.0001) but significantly and positively correlated with aspartate tranaminase levels (R = 0.16, p = 0.01) and alanine transaminase levels (R = 0.22, p = 0.007). However, IL-10 levels did not have a good predictive value in discriminating those who were likely to develop SD (AUC = 0.66). Serum IFNγ levels were also significantly higher (p = 0.04) in patients with SD when compared to non SD. There was no difference (p = 0.34) in serum IFNα levels and serum MIF levels (p = 0.15) in patients with SD and non SD. CONCLUSION: Although serum IL-10 was significantly elevated in patients with SD it had a poor discriminatory value in identifying those with SD and non SD and therefore, is unsuitable to be used as a robust biomarker in this cohort. |
format | Online Article Text |
id | pubmed-3733887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37338872013-08-06 Serum IL-10 as a marker of severe dengue infection Malavige, Gathsaurie Neelika Gomes, Laksiri Alles, Lukmall Chang, Thashi Salimi, Maryam Fernando, Sachie Nanayakkara, Kushan DL Jayaratne, SD Ogg, Graham S BMC Infect Dis Research Article BACKGROUND: Several studies have shown that serum IL-10, IFNγ and MIF are elevated in patients in severe dengue (SD) and could be used as potential biomarkers. We proceeded to determine if these cytokines could be used as biomarkers in a large cohort of adult dengue patients with varying severity of dengue infection. METHODS: Serum IL-10 levels were determined in 259 of whom 40 had severe dengue infection. Serum IFNγ and IFNα levels were done in 78 and MIF levels were done in 65 patients with acute dengue infection. Clinical features and laboratory investigations were undertaken during the febrile and critical phase. RESULTS: We found that serum IL-10 levels were significantly higher (p = 0.001) in patients with SD, when compared to those with non SD. Serum IL-10 levels significantly and inversely correlated with white cell counts (R = −0.23, p = 0.0002) and lymphocyte counts (R = −0.29, p < 0.0001) but significantly and positively correlated with aspartate tranaminase levels (R = 0.16, p = 0.01) and alanine transaminase levels (R = 0.22, p = 0.007). However, IL-10 levels did not have a good predictive value in discriminating those who were likely to develop SD (AUC = 0.66). Serum IFNγ levels were also significantly higher (p = 0.04) in patients with SD when compared to non SD. There was no difference (p = 0.34) in serum IFNα levels and serum MIF levels (p = 0.15) in patients with SD and non SD. CONCLUSION: Although serum IL-10 was significantly elevated in patients with SD it had a poor discriminatory value in identifying those with SD and non SD and therefore, is unsuitable to be used as a robust biomarker in this cohort. BioMed Central 2013-07-24 /pmc/articles/PMC3733887/ /pubmed/23883139 http://dx.doi.org/10.1186/1471-2334-13-341 Text en Copyright © 2013 Malavige et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Malavige, Gathsaurie Neelika Gomes, Laksiri Alles, Lukmall Chang, Thashi Salimi, Maryam Fernando, Sachie Nanayakkara, Kushan DL Jayaratne, SD Ogg, Graham S Serum IL-10 as a marker of severe dengue infection |
title | Serum IL-10 as a marker of severe dengue infection |
title_full | Serum IL-10 as a marker of severe dengue infection |
title_fullStr | Serum IL-10 as a marker of severe dengue infection |
title_full_unstemmed | Serum IL-10 as a marker of severe dengue infection |
title_short | Serum IL-10 as a marker of severe dengue infection |
title_sort | serum il-10 as a marker of severe dengue infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733887/ https://www.ncbi.nlm.nih.gov/pubmed/23883139 http://dx.doi.org/10.1186/1471-2334-13-341 |
work_keys_str_mv | AT malavigegathsaurieneelika serumil10asamarkerofseveredengueinfection AT gomeslaksiri serumil10asamarkerofseveredengueinfection AT alleslukmall serumil10asamarkerofseveredengueinfection AT changthashi serumil10asamarkerofseveredengueinfection AT salimimaryam serumil10asamarkerofseveredengueinfection AT fernandosachie serumil10asamarkerofseveredengueinfection AT nanayakkarakushandl serumil10asamarkerofseveredengueinfection AT jayaratnesd serumil10asamarkerofseveredengueinfection AT ogggrahams serumil10asamarkerofseveredengueinfection |